In Model 3, fully adjusted, the ORs for CKM Syndrome across SII quartiles Q2, Q3, and Q4 were 1.19 (1.04–1.36, p = 0.010), 1.40 (1.21–1.62, p < 0.0001), and 1.60 (1.39–1.83, p < 0.0001), respectively, highlighting a significant trend ( p for trend < 0.0001).
← all excerpts
Association between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome.
1
—
—